French female athletes have been excluded from the World Championship by the World Boxing Federation.
Early chromosome and SRY tests (1960s–1990s)
At the Olympic Games from 1968 onwards, the IOC introduced mandatory “sex tests.”
Initially simple physical examinations, then chromatin tests (Barr bodies), and later also SRY gene tests.
Reason: To prevent men from competing in women’s competitions.
Ewa Kłobukowska (Poland, 1967)
European champion, Olympic medalist in athletics.
Failed an early chromosome test → she had XX/XY mosaicism (intersex variation).
Result: Lifetime ban, even though she bore no responsibility.
María José Martínez-Patiño (Spain, 1985)
Hurdler.
Chromosome test showed 46,XY → she had the SRY gene and Androgen Insensitivity Syndrome (AIS).
Her body developed as female, and she had no advantage from testosterone (because the androgen receptors did not function).
Nevertheless, she was excluded from competition.
Later, she strongly campaigned against these tests – with success: in 1999, the IOC abolished blanket chromosome testing.
Caster Semenya (South Africa, since 2009)
800m runner, multiple world and Olympic champion.
Examinations revealed 46,XY with functional SRY → testes produced testosterone.
The International Association of Athletics Federations (IAAF, now World Athletics) therefore introduced testosterone limits:
Female athletes with XY/DSD and SRY must lower their testosterone levels medically in order to compete.
Semenya today (as of 2025) is no longer allowed to compete in her preferred events because she does not want to take medication.
Other known cases
Several anonymous DSD athletes at World Championships and Olympic Games have been flagged in recent decades, but their names were often not disclosed (privacy protection).
The issue was always the same: SRY gene present → development with increased testosterone → athletic advantage in women’s category.
Conclusion
The presence of the SRY gene was decisive in some cases for top-level performances in women’s sport.
Most famous examples:
Martínez-Patiño (AIS, Spain) → no advantages, but excluded.
Caster Semenya (XY with SRY, South Africa) → likely advantages due to higher androgen effects.